(Q40544962)

21 September 2017

title

Holotranscobalamin as a predictor of vitamin B12 status (English)

1 reference

21 September 2017

0 references

0 references

Anne-Mette Hvas

1

1 reference

21 September 2017

Ebba Nexo

series ordinal

2

1 reference

21 September 2017

publication date

1 November 2003

1 reference

Clinical Chemistry and Laboratory Medicine

21 September 2017

published in

1 reference

21 September 2017

volume

41

1 reference

21 September 2017

issue

11

1 reference

21 September 2017

page(s)

1489-1492

1 reference

Current concepts in cobalamin deficiency

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.228

False low serum vitamin B12 values with radiodilution assays using blocked R-binders

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.228

Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.228

Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.228

Low holotranscobalamin II is the earliest serum marker for subnormal vitamin B12 (cobalamin) absorption in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.228

RIA for serum holo-transcobalamin: method evaluation in the clinical laboratory and reference interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.228

The transcobalamin (TC) codon 259 genetic polymorphism influences holo-TC concentration in cerebrospinal fluid from patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.228

21 January 2018

Identifiers

DOI

10.1515/CCLM.2003.228

1 reference

21 September 2017

1 reference